* COMPLETED DEVELOPMENT OF ITS FIRST-GENERATION PRODUCTION PROCESS FOR ITS PROPRIETARY CAR-TREG TECHNOLOGY
* NEW FDA CLEARANCE VALIDATES IN VIVO, REAL-TIME “IDENTIFICATION OF CELLULAR AND VASCULAR ORGANIZATION AND ARCHITECTURE” USING CELLVIZIO®
* PFIZER INC - BOARD OF DIRECTORS APPROVES INCREASE IN QUARTERLY CASH DIVIDEND TO $0.34 PER SHARE AND AUTHORIZES NEW $10 BILLION SHARE REPURCHASE PROGRAM
Dec 18 Pfizer Inc said on Monday its board had authorized a new $10 billion share repurchase program and raised its quarterly dividend.
* SIGNS COOPERATION AGREEMENT BETWEEN CO, MCT (MEDYCZNYM CENTRUM TELEMONITORINGU SP. Z O. O.) AND ZENTRUM FÜR TELEMEDIZIN BAD KISSINGEN GMBH
No related earnings announcements are currently scheduled within the next 7 days.